Table 1.

Baseline data of the study population (n=1531)*†

Gender
Female	750 (49.20%)
Age	61.37 (10.90)
Educational level
Low	699 (53.60%)
Middle	467 (35.80%)
High	138 (10.60%)
Diabetes duration (years)	7.00 (4.00–12.00)
Complications
0	881 (62.70%)
≥1	523 (37.30%)
Comorbidities
0	1367 (89.30%)
≥1	164 (10.70%)
HbA1c
mmol/mol	69.32 (16.45)
%	8.49 (1.51)
Body mass index	30.53 (6.27)
Treatment
Oral agents	1021 (66.70%)
Insulin	510 (33.30%)
Symptomatic hypoglycemia during the past 3 months (self-report)
0 episode	584 (48.90%)
≥1 episode	610 (51.10%)
Severe hypoglycemia during the past 3 months (self-report)
0 episode	1191 (94.30%)
≥1 episode	72 (5.70%)
WHO-5 score (well-being)	60.00 (40.00–76.00)

*Based on non-imputed data.

†For categorical variables: frequencies (valid percentages); for normally distributed continuous variables: mean (SD); for skewed distributed continuous variables: median (25th–75th percentile).

HbA1c, hemoglobin A1c.